Summary
Latest filing:
Oliver J. Spandow is Director of NEPHROS INC (NEPH). 1 SEC Form 4 filing on record, dated 13 November 2025.
Recent Transactions
1Every recent SEC Form 4 transaction Oliver J. Spandow has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Oliver J. Spandow's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Carlyle Mozart Coinvestment Holdings, L.P. - $1.63B of MDLN open-market activity in the last 12 months
- Carlyle Group Inc. - $1.63B of MDLN open-market activity in the last 12 months
- WARBURG PINCUS CO. - $1.12B of SHC open-market activity in the last 12 months
- TC Group Cayman Investment Holdings, L.P. - $1.07B of MDLN open-market activity in the last 12 months
- CP Circle ML Holdco GP, LLC - $1.07B of MDLN open-market activity in the last 12 months
- GIC Private Ltd - $812.73M of MDLN open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Oliver J. Spandow?
Oliver J. Spandow is a corporate insider, tracked as Director of NEPHROS INC (NEPH). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Oliver J. Spandow last file a Form 4?
The only primary Form 4 on record is dated 13 November 2025.
Where can I see all of Oliver J. Spandow's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Oliver J. Spandow and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
